Current and emerging therapies in large-vessel vasculitis.

about

Current and emerging therapies in large-vessel vasculitis.

Item

http://www.wikidata.org/entity/Q50082820

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current and emerging therapies in large-vessel vasculitis.

@en

Current and emerging therapies in large-vessel vasculitis.

@nl

type

Item

label

Current and emerging therapies in large-vessel vasculitis.

@en

Current and emerging therapies in large-vessel vasculitis.

@nl

prefLabel

Current and emerging therapies in large-vessel vasculitis.

@en

Current and emerging therapies in large-vessel vasculitis.

@nl

P1476

Current and emerging therapies in large-vessel vasculitis.

@en

P2093

Bhaskar Dasgupta

http://www.w3.org/2001/XMLSchema#string

Tanaz A Kermani

http://www.w3.org/2001/XMLSchema#string

P2860

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.

Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.

Th17 and Th1 T-cell responses in giant cell arteritis.

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEX385

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29069518

http://www.w3.org/2001/XMLSchema#string